These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8523041)

  • 21. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
    Wittmann HJ; Seifert R; Strasser A
    Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.
    Wieland K; Laak AM; Smit MJ; Kühne R; Timmerman H; Leurs R
    J Biol Chem; 1999 Oct; 274(42):29994-30000. PubMed ID: 10514483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of specific H1-receptor agonists histaprodifen and its Nalpha-substituted analogues on bovine aortic H1-receptors.
    Carman-Krzan M; Bavec A; Zorko M; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):538-46. PubMed ID: 12669185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of histamine to the H1 receptor-a molecular dynamics study.
    Söldner CA; Horn AHC; Sticht H
    J Mol Model; 2018 Nov; 24(12):346. PubMed ID: 30498974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological properties of cardiovascular histamine H1 receptor binding sites: characterisation with 2-phenylhistamines.
    Carman-Krzan M; Krzan M; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):431-7. PubMed ID: 9109357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
    Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents].
    Differding E; Gillard M; Moguilevsky N; Varsalona F; Noyer M; Daliers J; Goldstein S; Neuwels M; Lassoie MA; Guillaume JP; Bascour M; Bollen A; Hénichart JP
    J Pharm Belg; 1996; 51(3):155-60. PubMed ID: 8778348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of amino acid residues responsible for agonist-induced down-regulation of histamine H(1) receptors.
    Horio S; Ogawa M; Kawakami N; Fujimoto K; Fukui H
    J Pharmacol Sci; 2004 Apr; 94(4):410-9. PubMed ID: 15107581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new model for the agonistic binding site on the histamine H2-receptor: the catalytic triad in serine proteases as a model for the binding site of histamine H2-receptor agonists.
    Nederkoorn PH; Vernooijs P; Donné-Op den Kelder GM; Baerends EJ; Timmerman H
    J Mol Graph; 1994 Dec; 12(4):242-56. PubMed ID: 7696215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms.
    Strasser A; Striegl B; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Jan; 324(1):60-71. PubMed ID: 17928567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of histamine H
    Díaz Nebreda A; Zappia CD; Rodríguez González A; Sahores A; Sosa M; Burghi V; Monczor F; Davio C; Fernández N; Shayo C
    Eur J Pharmacol; 2019 Mar; 847():42-52. PubMed ID: 30685431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
    Wittmann HJ; Seifert R; Strasser A
    Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the activation mechanism of the guinea-pig Histamine H1-receptor.
    Strasser A; Wittmann HJ
    J Comput Aided Mol Des; 2007 Sep; 21(9):499-509. PubMed ID: 17712599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Analysis of the Histamine H
    Shiroishi M; Kobayashi T
    Handb Exp Pharmacol; 2017; 241():21-30. PubMed ID: 27826702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two threonine residues and two serine residues in the second and third intracellular loops are both involved in histamine H1 receptor downregulation.
    Horio S; Kato T; Ogawa M; Fujimoto K; Fukui H
    FEBS Lett; 2004 Aug; 573(1-3):226-30. PubMed ID: 15328002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.